Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669686 | 0.77 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL868200 | 0.75 | — | — | |
| SCHEMBL4326668 | 0.75 | ALDH1A1 (0.36) | — | |
| SCHEMBL9980489 | 0.73 | NAAA (0.35) | — | |
| SCHEMBL4786240 | 0.72 | TRPA1 (0.34) | — | |
| SCHEMBL6025638 | 0.72 | — | — | |
| SCHEMBL18725980 | 0.71 | — | — | |
| SCHEMBL5670120 | 0.71 | TSHR (0.37) | — | |
| SCHEMBL23355066 | 0.69 | KDM2A (0.33) | — | |
| SCHEMBL18048859 | 0.69 | MGAM (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001096529-A2 | ACETYL GLUCOSAMINYL INOSITOL DEACETYLASE, A MYCOTHIOL BIOSYNTHETIC ENZYME, AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) | 2001-12-20 | — | — | WO | claimed |
| EP-4069868-A2 | METHODS OF DETECTION AND ANALYSIS OF NUCLEIC ACID IN NEURAL-DERIVED EXOSOMES | The Institute For Ethnomedicine DBA Brain Chemistry Labs (US) | 2022-10-12 | — | — | EP | disclosed |
| WO-2020065047-A1 | METHOD FOR THE STEREOISOMERIZATION OF CHIRAL COMPOUNDS | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2020-04-02 | — | — | WO | disclosed |
| US-7148069-B2 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO., INC. (JP) | 2006-12-12 | — | — | US | disclosed |
| WO-2005110494-A2 | METHODS AND COMPOSITIONS FOR THE INHIBITION OF THROMBUS FORMATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2005-11-24 | — | — | WO | disclosed |
| US-20050079624-A1 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO., INC (JP) | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050079624-A1 | Method for analysis of compounds with amino group and analytical reagent therefor | CTH, VIP, SLC7A11 | ALOX15 2880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.